Todd Stone
Physician Assistant · Hendersonville, NCNPI 1114910767
Payments from drug & device makers
Across 542 payments — averaging $19.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$1K
- Teva Pharmaceuticals USA, Inc.$1K
- AstraZeneca$900
- Otsuka America Pharmaceutical, Inc.$666
- Vanda Pharmaceuticals Inc.$649
- Lilly USA, LLC$621
- plus $5K from 35 others
What the payments were for
- Food & beverage$10,476100%
- Education$90%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$10,485 in reported general payments places this provider in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| OzempicSemaglutide | 58 | $67,870 |
| XareltoRivaroxaban | 72 | $53,141 |
| JardianceEmpagliflozin | 39 | $42,943 |
| EliquisApixaban | 50 | $39,826 |
| TrulicityDulaglutide | 21 | $30,978 |
| MounjaroTirzepatide | 19 | $27,916 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 21 | $26,067 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 25 | $24,938 |
| RybelsusSemaglutide | 11 | $23,919 |
| SynjardyEmpagliflozin/Metformin Hcl | 13 | $23,269 |
| RexultiBrexpiprazole | 13 | $18,195 |
| Toujeo SolostarInsulin Glargine,hum.Rec.Anlog | 13 | $16,558 |
| VascepaIcosapent Ethyl | 20 | $12,975 |
| Stiolto RespimatTiotropium Br/Olodaterol Hcl | 16 | $10,685 |
| Anoro ElliptaUmeclidinium Brm/Vilanterol Tr | 23 | $10,269 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Novo NordiskOzempic, Rybelsus | $333 | $91,78869 claims |
| Boehringer IngelheimJardiance, Synjardy, Stiolto Respimat | $346 | $76,89668 claims |
| Lilly USA, LLCTrulicity, Mounjaro | $621 | $58,89440 claims |
| Johnson & JohnsonXarelto | $217 | $53,14172 claims |
| PfizerEliquis | $148 | $39,82650 claims |
| AstraZenecaBreztri Aerosphere, Symbicort | $900 | $35,28852 claims |
| GSKTrelegy Ellipta, Anoro Ellipta | $112 | $35,20748 claims |
| Otsuka America Pharmaceutical, Inc.Rexulti | $666 | $18,19513 claims |
| NovartisEntresto | $93 | $9,79212 claims |
| AbbVieSynthroid | $1,198 | $2,44438 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 7,441 physician assistant providers in North Carolina.
Other physician assistant in Hendersonville
- Jo HughesGreensboro$814K
- Rachel HolzhauerCharlotte$739K
- Amber BlairCharlotte$551K
- Benjamin EpsteinDavidson$447K
- Rebecca KrausDavidson$425K
- Brooke JonesGoldsboro$259K
- Philip ReasbeckWilson$180K
- Katherine SchultzHuntersville$164K
- Kristin CabedaCharlotte$135K
- Jay ClarkeArden$133K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.